CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 8,800 shares at $2.26 ($19,888)
- 4 Open-market buy President, Science & Tech. bought 11,312 shares at $2.19 ($24,763)
- 4 Open-market buy Director bought 22,725 shares at $2.21 ($50,322)
- 4 Open-market buy Chief Commercial Officer bought 22,170 shares at $2.27 ($50,215)
- 4 Open-market buy Director bought 4,405 shares at $2.27 ($9,982)
- 4 Open-market buy President & CEO bought 45,000 shares at $2.24 ($100,778)
- 4 Open-market buy Director bought 11,061 shares at $2.28 ($25,261)
- 4 Open-market buy General Counsel bought 6,600 shares at $2.27 ($14,979)
- 4 Derivatives Options or other derivatives
Page 1 of 7 · 139 filings